Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

159 MoFo Attorneys Named in Best Lawyers in America 2026

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

Morrison Foerster achieved significant recognition in the 2026 edition of Best Lawyers in America, with 159 attorneys receiving...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Morrison Foerster achieved significant recognition in the 2026 edition of Best Lawyers in America, with 159 attorneys receiving 247 individual accolades across practices and offices in the United States.Six MoFo attorneys received “Lawyer of the Year” designations, including:<ul><li>Daralyn J. Durie - Bet-the-Company Litigation</li><li>Jill H. Feldman - Banking and Finance Law</li><li>L. Richard Fischer - Financial Services Regulation Law</li><li>Philip J. Levine - Real Estate Law</li><li>Ragesh K. Tangri - Trade Secrets Law</li><li>Steve Rowles - Corporate Governance Law</li></ul>Six MoFo attorneys were recognized as “Best Lawyers” for the first time in the 2026 edition, including:<ul><li>Christin J. Hill - Litigation: Securities</li><li>Damien C. Specht - Government Contracts</li><li>Jim Krenn - Mergers and Acquisitions Law</li><li>Karen J. Kubin - Litigation: Labor and Employment</li><li>Richard M. Nugent - Tax Law</li><li>Steve Tyndall - Corporate Law</li></ul>A further 35 MoFo attorneys were newly recognized as “Ones to Watch”.Established in 1983, Best Lawyers is one of the oldest and most respected peer‑review publications in the legal profession. Lawyers are selected based on receiving the highest overall peer feedback. Only one lawyer for each specialty and location is designated as a Lawyer of the Year.View the <a href="https://www.bestlawyers.com/" target="_blank">complete list of this year’s rankings</a>.

159 MoFo Attorneys Named in Best Lawyers in America 2026

Sign Up

Daralyn Durie is among the top trial lawyers in the country, acting as go-to trial counsel for both plaintiffs and defendants. Daralyn’s exceptional track record has earned her consistent recognition from leading national publications. Chambers has listed her among the top 10 intellectual property lawyers in the U.S. and Law360 has recognized her as an “Icon of IP” and an MVP. Benchmark Litigation reported that “going against her was like going against a boxer in which you know you’re going to get hurt.” She’s a fellow in the American College of Trial Lawyers, a member of the American Board of Trial Advocates, and an inductee into the California Trial Lawyer Hall of Fame.Daralyn’s legal career began at Berkeley Law, followed by a clerkship for the Honorable Douglas Ginsburg on the U.S. Court of Appeals for the District of Columbia Circuit. She became a partner at a litigation boutique in 1999 and, in 2009, co-founded Durie Tangri, a premier litigation boutique that later combined with Morrison Foerster in 2023.In addition to her courtroom successes, Daralyn is actively involved in the legal community. She is a board member of the National Women’s Law Center, a past president of the Northern California Association of Business Trial Lawyers, and served as an adjunct professor at Berkeley Law, where she taught civil trial advocacy.Life SciencesDaralyn has decades of experience in the life sciences sector. She spearheaded the enforcement of Genentech’s Cabilly family of patents, which generated billions of dollars in licensing revenue. She served as lead counsel in the Herceptin biosimilar litigation and recently achieved a plaintiff-side jury verdict of $178 million in a patent infringement case involving melanoma therapy.TechnologyIn the tech sector, Daralyn recently won defense jury verdicts for Aptiv (USB hubs), Activision (in the Eastern District of Texas), and Redbubble. She served as lead counsel for Google, defending Google Books from copyright infringement claims. Following extensive litigation on copyright and antitrust issues, Google prevailed on summary judgment, resulting in Daralyn being named an Attorney of the Year by California Lawyer magazine.

Daralyn Durie

Partner

Jill’s practice focuses on international and domestic commercial finance transactions, with a special emphasis on domestic and international, bilateral, and syndicated commercial lending and FinTech and impact investing credit transactions.Her diverse client mix includes:<ul><li dir="ltr">Agent banks, lenders, and borrowers in connection with domestic and international working capital facilities; acquisition finance credit agreements; agricultural and winery financings; and asset-based, equipment finance, and real estate secured credit facilities</li><li dir="ltr">Lenders and borrowers in connection with domestic and international FinTech lending transactions and impact lending in developing countries</li><li dir="ltr">Senior, subordinated, and pari-passu lenders in multi-tiered credit facilities</li><li dir="ltr">Investors in renewable energy facilities in connection with royalty-based development finance transactions</li></ul>Because her practice involves highly complex transactions, Jill often creates unique finance structures to meet the needs of her clients. She develops creative solutions that preserve her clients’ financial and operational objectives while accommodating the requirements of the other parties to the transaction. Her goal is the ultimate success of the deal and her clients’ satisfaction with the terms of those agreements.Jill has been recognized as a leading lawyer in Bank Lending by IFLR1000 in 2013, 2014, 2015, 2016 and 2024. She has also been recommended by Best Lawyers in America as a leading lawyer in Project Finance since 2013. Jill is also a member of our global Sustainability + Corporate Responsibility steering committee.

Jill Feldman

Senior Counsel

<div class="videoWrapper"><iframe title="Meet Washington, D.C. Senior Partner Rick Fischer" src="https://www.youtube-nocookie.com/embed/31XvoRyZXJc?rel=0" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen="1" title="iframe"></iframe></div>Rick has nearly 50 years of experience advising banks, retailers, insurers, and other companies throughout the United States on the full range of financial services and payment system issues. His practice focuses on retail financial services with a special emphasis on privacy, data security, e-commerce, and financial services joint ventures, as well as compliance and enforcement matters involving the Consumer Financial Protection Bureau, federal banking agencies, and the Federal Trade Commission.Rick has worked closely with clients on every major legislative and regulatory initiative affecting financial services and payment systems since the 1970s. He also has been successful in obtaining important legislative changes and regulatory clarifications relating to many retail banking and consumer lending issues.Ranked in U.S. News – Best Lawyers, The Legal 500, Chambers USA, and Chambers Global for his work in financial services and privacy and data security, Rick is ranked as a senior statesman, whose clients say, “Rick Fischer is the oracle on financial privacy law” (Chambers USA).

Rick Fischer

Senior Of Counsel

Phil Levine is head of the firm’s Northern California Real Estate Group. Phil concentrates his practice representing clients in a wide range of commercial real estate equity and debt transactions, including acquisitions and sales; ground lease transactions; financing (including permanent and construction loans); the structuring and formation of joint ventures and other investment vehicles for the development, ownership, and operation of all major property types, such as multifamily projects, office buildings, and industrial projects (including transactions involving the use of operating partnership units); representing landlords and tenants on office, industrial and retail leasing transactions; and counseling clients on ground-up development projects, including negotiating architect and construction contracts and development management agreements. His clients include REITs, private equity firms, institutional investors (including domestic and foreign investors), and real estate development companies. In the recent words of clients, Phil is “the best lawyer [they] have worked with in [their] career. Very smart and solution-oriented.” (Chambers USA 2022)Phil is also a member of the firm’s Distressed Real Estate Group and has represented clients in connection with loan restructurings, deed in lieu transactions, foreclosures, REO dispositions and investments in the acquisition and restructuring of real estate debt and equity investments.The Daily Journal named Phil to its 2013 list of California’s top 25 real estate transactional lawyers. Phil is also recommended by Chambers USA (2025), Best Lawyers in America (2026), Who’s Who Legal (2022), Legal 500 US (2024), Super Lawyers (2020), and IFLR1000 (2025) (all publications based on client and peer recommendations).Phil is a member of national and local real estate trade organizations, including ULI and NAREIT, is a past member of the NAIOP National Forums, and has served on the Board of Directors of the Silicon Valley Chapter of NACORE.Phil recently served on the Board of Directors of Habitat for Humanity – Greater San Francisco and was Chairman of the Board’s Legal Committee. Phil has also been a Lecturer on real estate transactions at Stanford University School of Law.

Philip Levine

Ragesh Tangri brings diverse experience representing clients ranging from individuals to Fortune 100 companies in high-stakes intellectual property and trade secret disputes, in addition to commercial litigation and legal malpractice, in jurisdictions across the country. Ragesh regularly represents major technology companies, law firms, and individuals in their most significant disputes.Ragesh has litigated matters involving high-stakes breach of contract and tort claims, as well as legal malpractice and professional negligence claims arising from work done in a variety of underlying areas, including intellectual property litigation, patent prosecution, general corporate matters, and tax. He has, during several pleadings motions, obtained complete dismissal of all claims asserted against law firm clients.Ragesh also has substantial experience with intellectual property litigation, including representing Palo Alto Networks in trade secret and patent litigation, Uber in trade secret litigation, Intel in inventorship litigation, Google in a hotly contested trade secret action brought by Microsoft, and helping secure a $180M award for Cadence Design Systems in its long-running dispute with Avant! Corporation.Ragesh has earned consistent recognition as a top practitioner in California and across the United States. Among his numerous awards, Chambers recently highlighted his “excellent” skill “in handling a range of contentious IP proceedings” in its guide for trademark, copyright, and trade secret litigation, and clients have called him “incredibly diligent and smart.” Ragesh has also been repeatedly ranked by publications including Best Lawyers and IAM Patent 1000.Ragesh serves on the Boards of the Northern District Historical Society (president), the California Law Review, and the Shotgun Players. He is a past president of the Association of Business Trial Lawyers and the Edward J. McFetridge Inn of Court, a former member of the Board of Governors of the Bar Association of San Francisco, a former member of the Board of Governors of the Justice and Diversity Center, a former member and co‑chair of the Lawyer Representatives of the Northern District of California to the Ninth Circuit Judicial Conference, a former member and chair of BASF’s Judiciary Committee, and a former member of the Board of Directors of Slow Food Nation. He has taught the Introduction to Civil Procedure and Law on Lawyering courses at Berkeley Law School and spoken frequently on issues, including trade secret law, professional negligence, ethics, claim construction, and the differences between the U.S. and Canadian legal systems.Ragesh earned his J.D. from the University of California, Berkeley School of Law. He clerked for the Hon. A. Raymond Randolph on the U.S. Court of Appeals for the District of Columbia Circuit. In 2009, Ragesh co‑founded Durie Tangri, a premier litigation boutique firm acquired by Morrison Foerster in 2022.

Ragesh Tangri

Steve Rowles is Chair of the firm’s San Diego Corporate Group. He has practiced in San Diego for over 25 years and has a wealth of experience as corporate counsel to public and private companies, and the venture capital and private equity funds that invest in those companies.He counsels companies at all stages in their life cycles. He distinguishes himself by achieving successful outcomes for clients utilizing best in class negotiating skills and creative and strategic thinking. He has been instrumental in starting, building and exiting numerous emerging growth companies in a broad range of industries including biotech, medical devices, digital health, diagnostics, healthcare services, clean technology and renewable energy, cybersecurity, fintech, agtech, software, 5G, semiconductors, telecommunications, e-commerce, new media and social networking.Steve has served as lead counsel on myriad mergers and acquisitions and securities transactions, including public offerings aggregating in excess of $2 billion in proceeds and over 100 acquisition transactions.Steve serves as general counsel and handles ’34 Act compliance, public securities offerings, and corporate governance counseling for a substantial number of public companies.Steve is adept at handling venture capital financings for both companies and investors. His expertise in partnership and limited liability company matters has given him substantial experience in fund formation, joint ventures, and other strategic partnering transactions.Steve was a member of Phi Beta Kappa at Northwestern University and was elected to the Order of the Coif at Boalt Hall School of Law.Steve is active on behalf of Children’s Hospital and serves on the Board of Directors for both EvoNexus San Diego and the Jacobs Cushman San Diego Food Bank. Steve is an avid golfer, a voracious reader, and a family man.<h4>Representative Transactions</h4><h5>M&A</h5><ul><li>Represented ACEA Biosciences, Inc. in its $250 million acquisition by Agilent Technologies Inc. (NYSE: A)</li><li>Represented Acon Laboratories in its two complex cross-border acquisitions by Inverness Medical Innovations, Inc. totaling $375 million</li><li>Represented Adicet Bio, a biopharmaceutical company focused on the development of novel off-the-shelf universal immune cell therapies, in its announced merger with a wholly-owned subsidiary of resTORbio (NASDAQ: TORC) to create a combined publicly-traded biotechnology company</li><li>Represented Alaska Energy & Resources Company in its $170 million acquisition by Avista Corp. (NYSE: AVA)</li><li>Represented Astute Medical, a medical diagnostic company focused on high-risk medical conditions and diseases, in its $90 million sale to bioMérieux (EPA: BIM)</li><li>Represented Biotix, a private equity-backed developer and manufacturer of laboratory consumables and liquid handling solutions, in its sale to Mettler-Toledo (NYSE: MTD) for an undisclosed sum</li><li>Represented Biotix in its cross-border sale of PML Microbiologics to bioMérieux (EPA: BIM) for $30,000,000</li><li>Represented Clean Energy Fuels (NASDAQ: CLNE) in its sale of BAF Technologies, Inc. to Westport Innovations Inc. for $30 million</li><li>Represented Clean-Energy Fuels (NASDAQ: CLNE), a leading provider of natural gas fuel for transportation in North America, in the $155 million sale of its renewable gas business to BP p.l.c, a British multinational oil and gas company.</li><li>Represented Clean Energy Fuels (NASDAQ: CLNE), this provider of natural gas as an alternative fuel for vehicle fleets, in its sale for up to $180 million of components of its renewable natural gas business to BP (NYSE: BP</li><li>Represented Cogent, Inc. (NASDAQ: COGT) in its $943 million acquisition by 3M Company</li><li>Represented Compex Legal Services, Inc., one of the largest litigation and discovery support services firms in the nation, in its sale to Windjammer Capital, LP for cash and an earnout totaling approximately $230 million</li><li>Represented Deere & Company (NYSE: DE) in its acquisition of Precision Planting and certain South American operations for $190,000,000 from Monsanto (NYSE: MON and a contemporaneous multi-year precision ag collaboration with Monsanto and the Climate Corporation as well as in related divestiture transactions</li><li>Represented Deere & Company (NYSE: DE) in its acquisition of T-Systems for an undisclosed sum</li><li>Represented Live Nation, Inc. in its $354 million acquisition of the House of Blues</li><li>Represented MedfusionRx and certain affiliated entities in their sale to SXC Health Solutions for $100,000,000 plus undisclosed earnout payments</li><li>Represented Mentor Corporation in its $1.12 billion merger with Johnson & Johnson</li><li>Represented MTY Food Group Inc. in its successful tender offer for the shares of Papa Murphy’s Holdings, Inc. (NASDAQ: FRSH) in a transaction valued at $190 million</li><li>Represented Paladin Technologies Inc. in its merger with TekWorks Inc.</li><li>Advised Scoperta, an innovative solution provider in advanced materials development, in its acquisition by Oerlikon Group, one of the world's leading high-tech industrial groups.</li></ul><h5>Venture Capital</h5><ul><li>Represented ACEA Biosciences Inc., a developer of cell analysis instrumentation technologies, in a $30 million Series E Preferred Stock financing</li><li>Represented ACEA Therapeutics, Inc., a pharmaceutical company developing small molecule candidates for lung cancer and other indications, in its $20 million convertible note financing</li><li>Represented Adicet Bio in its $51,000,000 Series A Preferred Stock financing with OrbiMed, Novartis, and Pontifax and its $80,000,000 Series B Preferred Stock financing with Regeneron, Johnson & Johnson Innovation, KB Investment, Samsung Venture Investment, and prior investors</li><li>Represented Astute Medical, a medical diagnostic company focused on high-risk medical conditions and diseases in over $200 million of equity and debt financings</li><li>Represented Biotix in a restructuring of its $80,000,000 Series A Preferred Stock financing and its $6,000,000 Series B Preferred Stock financing with Ferrer Freeman and Grotech Ventures</li><li>Represented Cellics Therapeutics, Inc., developer of nanosponges with nanoparticle cores coated with red or white blood cell membranes which can be used to absorb a wide range of toxins, in preferred stock financings exceeding $30 million</li><li>Represented Cello Therapeutics, Inc., which uses nanosponge technology as a delivery mechanism for cancer therapeutics, in its $4.2 million Series A-2 financing, bringing its total Series A funds raised to $8 million</li><li>Represented ColorTokens, Inc., a leading cybersecurity company, in its $30 million convertible note financing and preferred stock financings exceeding $100 million</li><li>Represented Clean Energy Fuels Corp. (NASDAQ: CLNE) in over $100 million in investments in NG Advantage LLC</li><li>Represented Curology, Inc., a leading telemedicine provider of dermatology services and prescriptions, in over $60 million of preferred stock financings</li><li>Represented Curology, Inc. in its $30 million Series D preferred stock financing led by Institutional Venture Partners and Anthos Partners. We also represented Curology in a concurrent $11o million private tender offer in which IVP, Anthos, ACME Ventures and TriplePoint Capital purchased shares of common and preferred stock from existing shareholders</li><li>Represented Enterprise Partners in a $7,000,000 Series A-1 Preferred Stock financing by Enviance</li><li>Represented Eolas Therapeutics Inc., a start-up life sciences company in connection with a milestone based licensing transaction with AstraZeneca Inc. with upfront and contingent proceeds potentially in excess of $140 million</li><li>Represented Coupang LLC, a leading e-commerce company in Korea, in three preferred unit financings aggregating $500 million</li><li>Represented Geneos Therapeutics, Inc., a leader in the field of personalized cancer immunotherapy, in $22 million preferred stock financings</li><li>Represented Greenoaks Capital Partners, this entity and its affiliates as investors in over $100 million in equity financings, debt financings, and secondary transactions, including Coupang and several other prominent e-commerce companies</li><li>Represented Ignyta in its $500,000 Series A Preferred Stock financing and its $5,500,000 Series B Preferred Stock financing with City Hill Ventures</li><li>Represented Inertia Systems, Inc., a fast-growing provider of construction management, SAAS software solutions, in its $3.5 million convertible note financing led by Signia Ventures, as well as a $2.5 million extension of such note financing, for an aggregate of approximately $6 million in proceeds</li><li>Represented Netly, LLC, developer of last mile fiber optic networks, in its debt and equity financing led by Ubiquity Partners LLC, with an initial closing of $40 million with an aggregate maximum raise of $250 million</li><li>Represented Obsidian Sensors, Inc., a thermal imaging and sensor company, in its $25 million Series A financings</li><li>Represented The Pill Club Holdings, Inc., a digital health provider of birth control pills, in over $60 million of preferred stock financings</li><li>Represented Rakuten Medical, this biotechnology company developing a new class of precision targeted oncologic drugs, in over $470 million of equity financings</li><li>Represented VoloAgri Group, an agriculture technology company known for seed genetics, in over $150 million of preferred stock financings</li><li>Represented Xilio Therapeutics, Inc., an immunology company, it is $30 million Series A financing</li><li>Represented a lead investor in a $50 million Series D financing in Retrotope, Inc., a developer of a medical platform to treat degenerative diseases</li></ul><h5>Capital Markets</h5><ul><li>Represented Banc of America Securities, Lehman, Thomas Weisel Partners, and William Blair as underwriters in a $82,000,000 initial public offering by Nuvasive</li><li>Represented Cardium Therapeutics in its $20,000,000 PIPE financing and $10,000,000 credit facility</li><li>Represented Clean Energy Fuels (NASDAQ: CLNE) in its $110 million at-the-market offering</li><li>Represented Clean Energy Fuels (NASDAQ: CLNE) in a 144A offering of Convertible Senior Notes in the aggregate principal amount of $250 million</li><li>Represented Clean Energy Fuels (NASDAQ: CLNE) in debt financing transactions with proceeds in excess of $500 million</li><li>Represented Digirad in its $66,000,000 initial public offering with Merrill Lynch, JP Morgan, Banc of America Securities, and William Blair as underwriters</li><li>Represented Fulgent Genetics, Inc. (NASDAQ: FLGT) in its $43.5 million initial public offering</li><li>Represented Harrow Health, Inc. (NASDAQ: HROW) in its $14 million initial underwritten public offering</li><li>Represented Ignyta in its going-public transaction through a reverse merger with a public company and its contemporaneous $47,000,000 PIPE financing with Landenburg Thalman as placement agent and its subsequent $7,000,000 PIPE financing with National Securities Corporation as placement agent</li><li>Represented Inovio Pharmaceuticals, Inc. in a $30 million registered direct offering</li><li>Represented OncoSec Medical Incorporated (NASDAQ: ONCS) in a registered direct offerings aggregating in excess $80 million</li><li>Represented RxElite in its $30,000,000 PIPE financing</li><li>Represented Santarus in its $62,000,000 initial public offering with Cowen, UBS, Thomas Weisel Partners, and RBC Capital Markets as underwriters</li></ul>

Steve Rowles

Christin Hill is a partner in Morrison Foerster’s San Francisco office and a member of the firm's Securities Litigation group. Christin has extensive experience representing clients in securities class actions, derivative actions and other complex civil litigation in both federal and state courts, as well as in government and internal investigations.With over a decade of experience in private practice, Christin has successfully represented public companies and their boards of directors and officers in securities fraud actions, derivative actions, SEC enforcement actions, internal investigations, and general corporate counseling. She also has experience working with pre-IPO companies in complex civil litigation in both federal and state court, internal investigations, responding to government inquiries, and advising on general compliance matters.Before joining Morrison & Foerster, Christin served as senior counsel at Uber Technologies, Inc., where she managed complex civil litigation including consumer class actions, intellectual property matters, and government investigations. She was also a lead member of Uber’s global compliance team, through which she created and implemented new compliance policies and training programs and advised company management in responding to government inquiries.Christin also served as an assistant district attorney in the San Francisco District Attorney’s Office, where she successfully prosecuted three misdemeanor criminal jury trials. Early in her career, she served as a judicial clerk for the Honorable John A. Houston in the U.S. District Court for the Southern District of California.

Christin Hill

Damien is a partner in the firm’s Government Contracts & Public Procurement practice. Damien represents clients in all facets of government contracts transactions, as well as regulatory counseling, subcontract and teaming agreement negotiations, contract disputes, size protests, and protests. Damien has been recognized as a leading Government Contracts lawyer by various publications. Chambers USA explains that he “is a strong choice for advising government contractors on M&A transactions,” with sources saying that he has “excellent knowledge of government contracts M&A” and that “his biggest strength is that he is very commercial, thinking about both the legal and business side of things.” National Law Journal named him a Trailblazer and found that federal lawmakers turn to him when they “need expert advice about small-business policy.”Damien has played a significant role in more than 200 government contracts transactions, representing industry leaders, private-equity firms and entrepreneurs. He also regularly serves as lead counsel in high-stakes litigation, including pre- and post-award protests at the GAO, the U.S. Court of Federal Claims, and state tribunals, as well as in size protests and appeals.The co-editor of books on small business litigation and government contracts transactions, Damien was a founding member of the ABA Public Contract Law Section Mergers and Acquisitions Committee and serves in the leadership of the American Bar Association Small Business & Other Socioeconomic Programs Committee. Damien has testified about procurement issues before the United States House of Representatives.<h4>GAO PUBLISHED DECISIONS</h4><ul><li>Dawson Solutions, LLC, B-418587, B-418587.2, Jun. 19, 2020, 2020 CPD ¶ 216</li><li>LATA-Atkins Technical Services, LLC, B-418602,B-418602.4, Jun. 10, 2020, 2020 WL 3265159</li><li>Inquiries, Inc., B-418486, B-418486.2, B-418486.3, May 27, 2020, 2020 WL 3034820</li><li>BEAT, LLC, B-418235, B-418235.2, Jan.30, 2020, 2020 CPD ¶ 64</li><li>Battelle Memorial Institute, B-416263.5, Jan. 23, 2020, 2020 WL 508726</li><li>ASRC Federal Data Network Technologies, LLC, B-418028; B-418028.2, Dec. 26, 2019, 2019 WL 7370424</li><li>IPKeys Technologies, LLC, B-416873.2, B-416873.3, Apr. 5, 2019, 2019 CPD ¶138</li><li>ActioNet, Inc., B-416557.4, February 27, 2019, 2019 CPD ¶ 97</li><li>Advanced Software Systems, Inc., B-414892.2, B-414892.3, B-414892.4, B-414892.5, B-414892.6, Jan. 7, 2019, 2019 CPD ¶ 51</li><li>Chenega Healthcare Services, LLC, B-416158, Jun. 4, 2018, 2018 CPD ¶ 200</li><li>Federal Acquisition Services Alliant JV, LLC, B-415406.2, B-415406.3, April 11, 2018, 2018 CPD ¶ 139</li><li>VT Halter Marine, Inc., B-415510.2, B-415510.3, B-415510.4, Jan. 24, 2018, 2018 CPD ¶ 62</li><li>OBXtek, Inc., B-415258, Dec. 12, 2017, 2017 CPD ¶ 381</li><li>Katmai Health Services, LLC, B-413816.3, Jul. 12, 2017, 2017 CPD¶ 220</li><li>Verdi Consulting, Inc., B-414103.2, B-414103.3, B-414103.4, Apr. 26, 2017, 2017 CPD ¶ 136</li><li>Threat Management Group, LLC, B-413729, Dec. 21, 2016, 2017 CPD ¶ 9</li><li>Analytic Strategies LLC; Gemini Industries, Inc.; B-413758.2, B-413758.3, Nov. 28, 2016, 2016 CPD ¶ 340</li><li>Kollsman, Inc., B-413485, B-413485.2, B-413485.3, Nov. 8, 2016, 2016 CPD ¶ 326</li><li>The Boeing Company, B-412441, Feb. 16, 2016, 2016 CPD ¶ 269</li><li>Ball Aerospace & Technologies Corp., B-411359; B-411359.2, Jun. 16, 2015, 2015 CPD¶ 219</li><li>IAP World Services, Inc.; EMCOR Government Services, B-407917.2, B-407917.3, B-407917.4, B-407917.5, B-407917.6, B-407917.7, 2013 CPD ¶ 171</li><li>AT&T Government Solutions, Inc. , B-406926, B-406926.2, B-406926.3, B-406926.4, B-406926.5, B-406926.6, 2013 CPD ¶ 88</li><li>Weibel Equipment, Inc., B-406888, B-406888.2, 2012 CPD ¶ 279</li><li>O'Gara Training and Services, LLC, B-404901.2, 2011 CPD ¶ 171</li><li>Harrington, Moran, Barksdale, Inc., B-401934.2, B-401934.3, 2010 CPD ¶ 231</li><li>CIGNA Government Services, LLC, B-401068.4, B-401068.5, 2010 CPD ¶ 230</li><li>ITT Corporation, Systems Division, B-310102.6, B-310102.7, B-310102.8, B-310102.9, 2010 CPD ¶ 12</li><li>FedSys, Inc., B-401453, 2009 CPD ¶ 181</li><li>Academy Facilities Management, B-401094.3, 2009 CPD ¶ 139</li><li>Honeywell Technology Solutions, Inc., B-400771; B-400771.2, 2009 CPD ¶ 49</li><li>TrailBlazer Health Enterprises, LLC, B-310801.6, B-310801.7, B-310801.10, 2013 CPD ¶ 204</li><li>Evans Security Solutions, Inc. , B-311035, 2008 CPD ¶ 58</li><li>DRS C3 Systems, LLC, B-310825; B-310825.2, 2008 CPD ¶ 103 </li></ul><h4>COFC PUBLISHED DECISIONS</h4><ul><li>AccelGov, LLC v. United States, 170 Fed. Cl. 508 (2024)</li></ul><ul><li>Acuity Edge, Inc. v. United States, 174 Fed. Cl. 46 (2024)</li></ul><ul><li>Alpine Cos., Inc. v. United States, 156 Fed. Cl. 681 (2021)</li></ul><ul><li>Navarro Rsch. & Eng’g, Inc. v. United States, 151 Fed. Cl. 184 (2020)</li></ul><ul><li>Next Phase Sols. & Servs., Inc. v. United States, 164 Fed. Cl. 15 (2023)</li></ul><ul><li>Noble Supply & Logistics LLC v. United States, 168 Fed. Cl. 439 (2023)</li></ul><ul><li>Quanterion Sols, Inc. v. United States, 157 Fed. Cl. 22 (2021)</li></ul><ul><li>HomeSource Real Estate Asset Servs. v. United States, No. 10-416 C, 94 Fed. Cl. 466 (Fed. Cl. 2010)</li><li>ACTA, LLC v. United States, No. 20-356C</li><li>Chenega Healthcare Servs., LLC v. United States, No. 18-861C, 141 Fed. Cl. 254 (Fed. Cl. 2019)</li><li>Trans Digital Techs., LLC v. United States, No. 18-121C, 138 Fed. Cl. 34 (Fed. Cl. 2018)</li><li>Precise Sys. v. United States, No. 14-1174C, 122 Fed. Cl. 263 (Fed. Cl. 2015)</li><li>Palladian Partners, Inc. v. United States, No. 14-317C, 119 Fed. Cl. 417 (Fed. Cl. 2014)</li><li>Pyramid Real Estate Servs., LLC v. United States, No. 10-599 C, 95 Fed. Cl. 613 (Fed. Cl. 2010)</li><li>Acad. Facilities Mgmt. v. United States, No. 09-302C, 87 Fed. Cl. 441 (Fed. Cl. 2009)</li><li>L-3 Communs. EOTech, Inc. v. United States, No. 08-515 C, 83 Fed. Cl. 643 (Fed. Cl. 2008)</li></ul>

Damien C. Specht

Jim Krenn is a corporate partner and chair of the firm’s Emerging Companies + Venture Capital Group.Jim has comprehensive experience representing emerging, growth-stage, and public companies, as well as angel, corporate, and institutional investors, in strategic transactions and corporate matters throughout the company lifecycle, from formation and early-stage financings through liquidity events and public company operations. Jim’s practice focuses on mergers and acquisitions, financings, and general corporate counseling, with a particular emphasis on life science and technology companies. He regularly advises boards of directors, executive teams, and investors on complex transactional matters, capital-raising activities, and corporate governance issues.In his mergers and acquisitions practice, Jim represents buyers and sellers in domestic and cross-border transactions across a wide range of structures, including mergers, stock and asset purchases, divestitures, joint ventures, and competitive sale processes. He has represented clients in acquisitions and sales ranging from the low millions to transactions exceeding $1 billion, for both private and public companies.Jim also counsels venture-backed and growth-stage companies in equity financings and ongoing corporate matters, and advises leading angel, corporate, and venture capital investors in their investments in such companies. He has represented clients in hundreds of venture capital and growth equity financings, from seed and early-stage rounds through $100 million-plus later-stage rounds.In addition, Jim represents public companies in initial public offerings, other capital markets transactions, and SEC reporting and compliance matters, and advises boards of directors on corporate governance issues. Jim is a member of the firm’s Life Sciences + Healthcare Group leadership team and Artificial Intelligence steering committee. He is actively involved in the startup and venture capital ecosystem, including  serving on the Board of Directors of the San Diego Entrepreneurs Exchange.<h4>Representative Transactions</h4><h5>Mergers and Acquisitions</h5><ul><li>ACEA Biosciences, a medical instruments company, in its sale to Agilent Technologies (NYSE: A) for $250 million.</li><li>Adicet Bio (Nasdaq: ACET), a biopharmaceutical company, in its merger with a wholly owned subsidiary of resTORbio (Nasdaq: TORC) to create a combined publicly traded biotechnology company.</li><li>Alaska Energy & Resources Company, a parent company of a regulated electric utility in Alaska, in its $170 million sale to Avista (NYSE: AVA).</li><li>Astute Medical, a medical diagnostic company, in its $90 million sale to bioMérieux (EPA: BIM).</li><li>B. Riley Financial (Nasdaq: RILY), a diversified financial services company, in its $53 million private placement and merger with investment banking firm B. Riley & Co.</li><li>Biotix, a private equity-backed developer and manufacturer of laboratory consumables and liquid handling solutions, in its sale to Mettler-Toledo (NYSE: MTD).</li><li>California Cryobank, a private equity-backed leader in reproductive tissue donor services and stem cell banking, in multiple acquisitions.</li><li>Clean Energy Fuels (Nasdaq: CLNE), a provider of natural gas as an alternative fuel for vehicle fleets, in its sale for up to $180 million of components of its renewable natural gas business to BP (NYSE: BP).</li><li>Cogent (Nasdaq: COGT), a biometric identification solutions provider, in its $943 million sale to 3M (NYSE: MMM).</li><li>Deere & Company (NYSE: DE), an agricultural, construction, and forestry machinery corporation, in its planned acquisition of the precision planting unit of Monsanto (NYSE: MON).</li><li>Dosatron International, a distributor of water-powered dosing pumps and systems, in connection with its sale to Ingersoll Rand (NYSE:IR).</li><li>Gillco, a leading specialty ingredient provider, in its sale to Azelis (BR: AZE).</li><li>Mentor (NYSE: MNT), a leading supplier of medical products for the global aesthetic market, in its $1.12 billion sale to Johnson & Johnson (NYSE: JNJ).</li><li>Mitchell International, a developer of smart technology solutions, in its acquisition of Cogent Works.</li><li>MyChem, a provider of ultra-pure nucleotides, in connection with its sale to Maravai (NASDAQ: MRVI) for $240 million at closing with potential additional consideration.</li><li>Protomer Technologies, a biotechnology company, in its sale to Eli Lilly and Company (NYSE: LLY) with a potential value of over $1 billion with successful achievement of future development and commercial milestones.</li><li>Rakuten Medical, a biotechnology and medical device company, in its acquisition of Medlight SA and its acquisition of key assets and manufacturing technology from Li-Cor Biosciences.</li><li>Safebuilt Insurance Services, a managing general agent and insurance technology company, in its sale to Integrated Specialty Coverages.</li><li>Sequlite Genomics, a DNA sequencing firm, in connection with its sale to Fapon Biotech, a diagnostic technology company.</li><li>Tendo, a digital health software company, in its acquisition of MDsave, a healthcare marketplace company.</li><li>Wavestream, a provider of high-power solid-state amplifiers, in its $137 million sale to Spacenet, a subsidiary of Gilat Satellite Networks (Nasdaq: GILT).</li></ul><h5>Equity Financings</h5><ul><li>9amHealth, a provider of virtual diabetes care, in its $4 million Series Seed financing and $16 million Series A financing.</li><li>ACEA Biosciences, a developer of cell analysis instrumentation technologies, in its $30 million Series E Preferred Stock financing.</li><li>Adicet Bio, a biopharmaceutical company, in its Series A financing of up to $51 million, and $80 million Series B financing.</li><li>Astute Medical, a medical diagnostic company focused on high-risk medical conditions and diseases, in over $200 million of equity and debt financings.</li><li>Bidra as an investor in multiple equity financings.</li><li>Biolumic, an agtech company, in its $13.5 million Series B financing.</li><li>California Cryobank, a private equity-backed leader in reproductive tissue donor services and stem cell banking, in multiple equity and debt financings.</li><li>Carlsmed, a medtech company pioneering AI-enabled personalized spine surgery solutions, in its $10 million Series A financing, $30 million Series B financing, $64.5 million Series C financing and $100.5 million initial public offering.</li><li>Corner Therapeutics, a biotech company, in its $54 million Series A financing.</li><li>Crinetics (Nasdaq:CRNX) as a strategic investor in Radionetics Oncology’s $52.5 million Series A financing.</li><li>Crinetics(Nasdaq:CRNX) in its $350 million PIPE financing, at-the-marketing offering of up to $350 million, $575 million underwritten public offering and $350 million underwritten public offering.</li><li>Forward Ventures as an investor in multiple equity financings, convertible debt financings, and M&A transactions.</li><li>Foxen, a provider of financial technology solutions for the real estate industry, in its $44 million Series A financing.</li><li>Greenoaks Capital Partners and its affiliates as investors in multiple equity financings, debt financings, and secondary transactions.</li><li>GroupSolver, an artificial intelligence market research platform, in multiple preferred stock financings.</li><li>Hume.ai, an artificial intelligence company, in multiple preferred stock financings.</li><li>Oak Investment Partners as an investor in multiple preferred stock financings.</li><li>OrbiMed as an investor in multiple equity financings, debt financings, and M&A transactions.</li><li>Petuum, an artificial intelligence and machine learning software infrastructure provider, in its $93 million Series B financing.</li><li>Pi Health, an AI-enabled health technology and clinical research company, in its spin-out from BeiGene, Ltd. and $35 million Series A financing.</li><li>Perceptive Advisors as an investor in multiple financings and transactions.</li><li>Presight Capital as an investor in multiple equity financings.</li><li>RA Capital as an investor in multiple equity financings.</li><li>Rakuten Medical, a biotechnology and medical device company, in over $800 million of debt and equity financings.</li><li>Rubi Laboratories, a company focused on converting carbon emissions into textiles, in multiple equity financings.</li><li>Softbank affiliates as investors in multiple equity financings.</li><li>Solarflare Communications, a technology company, in over $200 million of equity and debt financings.</li><li>Tendo Systems, a HealthTech software company, in its $20 million financing from Vistara.</li><li>Tutor Intelligence, an artificial intelligence robotics company, in its $34 million Series A financing.</li><li>VoloAgri, an ag-tech company, in over $150 million of equity financings.</li><li>Western Digital Capital as an investor in multiple preferred stock financings.</li></ul>

Jim Krenn

Chair of Emerging Companies + Venture Capital Practice

Richard Nugent is a partner in the firm’s New York office and chair of its Tax practice.Richard has over 25 years of experience advising on the tax aspects of complex transactions including public and private M&A, spin-offs, joint ventures, internal restructurings, and financings and capital markets transactions. He also advises debtors and creditors within and outside of bankruptcy.Richard has been recognized in Chambers USA, where he is praised as “an extremely knowledgeable and dedicated attorney” and “well-versed in communicating complex issues.” The Legal 500 describes Richard as having a “deep understanding of the business, including product supply, marketing, and distribution” which clients describe as “priceless when representing us in deal matters.” Prior to joining Morrison Foerster, Richard was a tax partner at another international law firm in New York. He serves on the Executive Committee of the New York State Bar Association Tax Section and is a member of the Tax Forum. A sought-after speaker, Richard frequently presents on tax topics for Practising Law Institute programs.Richard holds an LL.M. with distinction from Georgetown University, a J.D. with honors from Rutgers School of Law – Newark, and a B.A., summa cum laude, from Saint Peter’s University. He also served as a law clerk to Judge Richard F. Suhrheinrich of the U.S. Court of Appeals, Sixth Circuit and Judge Robert P. Ruwe of the U.S. Tax Court.<h4>Representative Experience</h4><ul><li>Represented Centuri Holdings and parent company Southwest Gas Holdings in $238 million public offering of common stock</li><li>Represented Paine Schwartz Partners, a global leader in sustainable food chain investing, in its investment in Chex Finer Foods, a value-added specialty food distributor</li><li>Represented the board of Continental Disc Corporation, a portfolio company of Tinicum, in connection to its sale to Baker Hughes, an energy technology company</li><li>Represented Hooter’s Inc. and Hoot Owl Restaurants, L.L.C. in the acquisition of over 100 restaurants from Hooters of America LLC, which filed for Chapter 11 protection on March 31st in the U.S. Bankruptcy Court</li><li>Represented Centuri Holdings and parent company Southwest Gas Holdings in $353 million IPO and concurrent private placement</li><li>Represented C2 Capital Partners in its investment in Stella & Chewy’s, a leading North American pet food manufacturer</li></ul>

Richard Nugent

Chair of the Tax Practice

Steve Tyndall is a corporate partner based in the firm’s Austin office.Steve has over 20 years of experience in corporate and securities law. He advises emerging and established companies at every step of their evolution, counseling on a broad range of corporate and transactional matters including venture financings, public and private offerings of equity and debt securities, mergers and acquisitions, and joint ventures.Steve also provides corporate governance guidance to his clients, including in connection with the preparation of periodic reports under the Securities Exchange Act of 1934 with respect to publicly held companies.While Steve advises across a wide range of industries, he offers particular experience in the energy-related technology and life sciences spaces.<h4>Representative Experience</h4><ul><li>Has advised public and private companies, private equity and venture funds, and Board committees in mergers, acquisitions, joint ventures, and other strategic transactions with an aggregate transaction value in excess of $1.5 billion.</li><li>Has represented issuers and investment banks in public offerings of equity and debt transactions with an aggregate transaction value in excess of $3 billion.</li><li>Has represented issuers and investors in private placements with an aggregate transaction value in excess of $500 million.</li></ul><h4>Rankings</h4><ul><li>Chambers USA: Technology: Corporate & Commercial (2020 – 2023)</li><li>Legal 500 US 2023: M&A / Corporate and Commercial: M&A: Large Deals ($1BN+)</li></ul>